This live web event has ended. Thank you for attending.
Enabling precision oncology care through collaboration: testing before treating ERBB2/HER2 mutations in mNSCLC
Why should you register now for this webinar?
Hear national thought leaders discuss the rapidly evolving biomarker landscape in metastatic non-small cell lung cancer (NSCLC), with the focus on emerging ERBB2/HER2 mutations, including exon 20 insertions. The oncologist and pathologist speakers will discuss their roles within the context of a multidisciplinary team to enable precision oncology care.
Brought to you by: CAP TODAY
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Presenters: Narjust Florez, MD, and Salvatore Priore, MD, PhD
What will this webinar empower you to do?
CAP TODAY does not endorse any of the products or services named within.
The webinar is made possible by a special educational grant from Thermo Fisher Scientific.